Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic's ICE COLD PCR for Biomarker ID

Transgenomic's Multiplexed ICE COLD PCR (MX-ICP) technology is now available as a service to pharmaceutical and biotechnology customers through the firm's Biomarker Identification business unit. MX-ICP is a highly sensitive DNA amplification technology that allows the detection of multiple mutations in multiple genes from any sample, either from a tumor biopsy or from liquids such as blood or urine. MX-ICP is validated and available for use on all sequencing platforms and can use either tissue or liquid biopsies.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.